L

Lytix Biopharma AS
LYTIX

Last Price

Lytix Biopharma AS Balance Sheet

Assets
Metric20182019202020212022202320242025
NOK130.791MNOK72.358M
NOK12.561MNOK7.078M
--
NOK552K-
--
NOK143.904MNOK79.436M
NOK2.631MNOK2.087M
--
--
--
-NOK999
NOK2.631MNOK2.088M
--
NOK146.535MNOK81.524M
Liabilities
Metric20182019202020212022202320242025
NOK11.558MNOK6.377M
--
NOK762KNOK977K
NOK762K-
--
--
NOK30.225MNOK11.198M
NOK36.764MNOK18.552M
NOK-1.878M-
NOK2.64MNOK1.222M
--
--
NOK-0.001MNOK-1.222M
NOK1.877MNOK1.222M
--
NOK38.641MNOK19.774M
Equity
Metric20182019202020212022202320242025
--
--
NOK6.816MNOK6.826M
--
NOK101.078MNOK54.923M
--
-NOK1K
NOK107.894MNOK61.75M
--
NOK107.894MNOK61.75M
NOK146.535MNOK81.524M
Other
Metric20182019202020212022202320242025
-NOK61.756M
NOK2.64MNOK3.421M
NOK-128.151MNOK-7.181M

Balance Sheet Composition

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.